siRNA-based approaches in cancer therapy
GR Devi - Cancer gene therapy, 2006 - nature.com
The availability of the human genome sequence has revolutionized the strategy of
employing nucleic acids with sequences complementary to specific target genes to improve …
employing nucleic acids with sequences complementary to specific target genes to improve …
siRNA therapeutics: big potential from small RNAs
RNA interference (RNAi) is now an umbrella term referring to post-transcriptional gene
silencing mediated by either degradation or translation arrest of target RNA. This process is …
silencing mediated by either degradation or translation arrest of target RNA. This process is …
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo
B Urban-Klein, S Werth, S Abuharbeid, F Czubayko… - Gene therapy, 2005 - nature.com
RNA interference (RNAi) represents a powerful, naturally occurring biological strategy for
inhibition of gene expression. It is mediated through small interfering RNAs (siRNAs), which …
inhibition of gene expression. It is mediated through small interfering RNAs (siRNAs), which …
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in …
L Zhang, N Yang, JW Park, D Katsaros, S Fracchioli… - Cancer research, 2003 - AACR
Vascular remodeling in host tissues surrounding growing tumors is implicated in the
successful development of tumor neovasculature. Cooperation between vascular …
successful development of tumor neovasculature. Cooperation between vascular …
Hairpin RNA: a secondary structure of primary importance
An RNA hairpin is an essential secondary structure of RNA. It can guide RNA folding,
determine interactions in a ribozyme, protect messenger RNA (mRNA) from degradation …
determine interactions in a ribozyme, protect messenger RNA (mRNA) from degradation …
Tyrosine kinase inhibitors in cancer therapy
S Madhusudan, TS Ganesan - Clinical biochemistry, 2004 - Elsevier
Cancer is the second leading cause of death in the western world. Despite advances in
diagnosis and treatment, overall survival of patients remains poor. Scientific advances in …
diagnosis and treatment, overall survival of patients remains poor. Scientific advances in …
Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
J Wu, Y Tang, X Liang - OncoTargets and therapy, 2018 - Taylor & Francis
Vascular normalization is a new concept of targeting angiogenesis to restore vessel
structure and function and to increase blood perfusion and delivery of drugs. It has been …
structure and function and to increase blood perfusion and delivery of drugs. It has been …
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key
factors in tumor angiogenesis that are up-regulated by hypoxia. We evaluated the effects of …
factors in tumor angiogenesis that are up-regulated by hypoxia. We evaluated the effects of …
VEGF function in vascular pathogenesis
YS Ng, D Krilleke, DT Shima - Experimental cell research, 2006 - Elsevier
Vascular endothelial growth factor (VEGF) has proven to be the most critical angiogenic
factor identified to date; its discovery has transformed the field of angiogenesis research …
factor identified to date; its discovery has transformed the field of angiogenesis research …
Therapeutic siRNAs
M Sioud - Trends in pharmacological sciences, 2004 - cell.com
The ability of small-interfering RNAs (siRNAs) to silence gene expression in somatic
mammalian cells has provided researchers with a novel tool to block the expression of …
mammalian cells has provided researchers with a novel tool to block the expression of …